Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Xavier Solanich, Raül Rigo‐Bonnin, Victor-David Gumucio, Paul Bastard, Jérémie Rosain, Quentin Philippot, Xosé Pérez-Fernández, Maria-Paz Fuset-Cabanes, Miguel-Ángel Gordillo-Benitez, Guillermo Suárez-Cuartín, Enric Boza-Hernández, Antoni Riera‐Mestre, Alba Parra-Martínez, Roger Colobrán, Arnau Antolí, Sergio Navarro‐Velázquez, Gemma Rocamora-Blanch, Mario Framil, Laura Calatayud, Xavier Corbella, Jean-Laurent Casanova, Francisco Morandeira, Joan Sabater‐Riera
Topics & Concepts
Coronavirus disease 2019 (COVID-19)AutoantibodyMedical microbiologyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyImmunologyIntensive careIntensive care medicineInternal medicineAntibodyDiseaseInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and Thrombosis